UNSPSC 51342707: Interferon alfacon-1

This classification denotes an interferon, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 56588OP40D. European Medicines Agency schedules Interferon alfa-2a in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB08199MIG. As of Q4 2014, INTERFERON ALFACON-1 remains the US FDA Preferred Term for this commodity. Interferon alfacon-1 bears US NLM identifiers UMLS ID C0164613 and NCI Concept Code C1766. SMILES: NONE.

UNSPSC 51342707 Interferon alfacon-1, a Commodity code, shows a material mismatch between its nominal scope and recent state and local procurement activity. The code designates a specific pharmaceutical antiviral agent, but the recent opportunities tagged under it reflect acquisition of emergency response medical supplies, naloxone and drug deactivation systems, direct-to-manufacturer prescription programs, and generic pharmaceuticals through cooperative purchasing — none of which involves interferon alfacon-1 specifically. State and local procurement systems have applied the code to broad medical product categories and pharmacy initiatives that fall outside the code's defined pharmaceutical substance. The issuing bodies soliciting under this code include county health departments (Seminole County, Florida), city fire departments (City of Tampa), state health agencies (Texas Health and Human Services Commission), and multistate cooperative purchasing alliances (Minnesota Multistate Cooperative Purchasing Alliance, serving state and local governments across multiple jurisdictions including Oregon).

Activity is spread across Florida, Texas, and the upper Midwest, with the cooperative purchasing channel representing the largest recent opportunity. Representative recent solicitations include Seminole County's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (posted June 30, 2026, response due July 26, 2023), the City of Tampa's invitation to bid for 169 line items of medical and first aid supplies for the Tampa Fire Department (posted March 25, 2026, due March 13, 2026, estimated contract value $700,000), the Texas HHS Commission's RFI on direct-to-manufacturer prescription programs (posted April 3, 2026), and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic pharmaceuticals and OTC products available to participating state and local government facilities (posted January 20, 2026, proposals due March 26, 2026, with performance effective July 1, 2026). The code shows active procurement volume but limited relevance to interferon alfacon-1 specifically; business development efforts under this code would be better grounded in the actual commodities and service models currently being solicited rather than the code's nominal pharmaceutical definition.